Automatic segmentation of anatomical structures is critical for many medical applications. However, the results are not always clinically acceptable and require tedious manual revision. Here, we present a novel concept called artificial intelligence assisted contour revision (AIACR) and demonstrate its feasibility. The proposed clinical workflow of AIACR is as follows given an initial contour that requires a clinicians revision, the clinician indicates where a large revision is needed, and a trained deep learning (DL) model takes this input to update the contour. This process repeats until a clinically acceptable contour is achieved. The DL model is designed to minimize the clinicians input at each iteration and to minimize the number of iterations needed to reach acceptance. In this proof-of-concept study, we demonstrated the concept on 2D axial images of three head-and-neck cancer datasets, with the clinicians input at each iteration being one mouse click on the desired location of the contour segment. The performance of the model is quantified with Dice Similarity Coefficient (DSC) and 95th percentile of Hausdorff Distance (HD95). The average DSC/HD95 (mm) of the auto-generated initial contours were 0.82/4.3, 0.73/5.6 and 0.67/11.4 for three datasets, which were improved to 0.91/2.1, 0.86/2.4 and 0.86/4.7 with three mouse clicks, respectively. Each DL-based contour update requires around 20 ms. We proposed a novel AIACR concept that uses DL models to assist clinicians in revising contours in an efficient and effective way, and we demonstrated its feasibility by using 2D axial CT images from three head-and-neck cancer datasets.
Typically, the current dose prediction models are limited to small amounts of data and require re-training for a specific site, often leading to suboptimal performance. We propose a site-agnostic, 3D dose distribution prediction model using deep learning that can leverage data from any treatment site, thus increasing the total data available to train the model. Applying our proposed model to a new target treatment site requires only a brief fine-tuning of the model to the new data and involves no modifications to the model input channels or its parameters. Thus, it can be efficiently adapted to a different treatment site, even with a small training dataset.
In this study, we propose a tailored DL framework for patient-specific performance that leverages the behavior of a model intentionally overfitted to a patient-specific training dataset augmented from the prior information available in an ART workflow - an approach we term Intentional Deep Overfit Learning (IDOL). Implementing the IDOL framework in any task in radiotherapy consists of two training stages: 1) training a generalized model with a diverse training dataset of N patients, just as in the conventional DL approach, and 2) intentionally overfitting this general model to a small training dataset-specific the patient of interest (N+1) generated through perturbations and augmentations of the available task- and patient-specific prior information to establish a personalized IDOL model. The IDOL framework itself is task-agnostic and is thus widely applicable to many components of the ART workflow, three of which we use as a proof of concept here: the auto-contouring task on re-planning CTs for traditional ART, the MRI super-resolution (SR) task for MRI-guided ART, and the synthetic CT (sCT) reconstruction task for MRI-only ART. In the re-planning CT auto-contouring task, the accuracy measured by the Dice similarity coefficient improves from 0.847 with the general model to 0.935 by adopting the IDOL model. In the case of MRI SR, the mean absolute error (MAE) is improved by 40% using the IDOL framework over the conventional model. Finally, in the sCT reconstruction task, the MAE is reduced from 68 to 22 HU by utilizing the IDOL framework.
Since the outbreak of the COVID-19 pandemic, worldwide research efforts have focused on using artificial intelligence (AI) technologies on various medical data of COVID-19-positive patients in order to identify or classify various aspects of the disease, with promising reported results. However, concerns have been raised over their generalizability, given the heterogeneous factors in training datasets. This study aims to examine the severity of this problem by evaluating deep learning (DL) classification models trained to identify COVID-19-positive patients on 3D computed tomography (CT) datasets from different countries. We collected one dataset at UT Southwestern (UTSW), and three external datasets from different countries: CC-CCII Dataset (China), COVID-CTset (Iran), and MosMedData (Russia). We divided the data into 2 classes: COVID-19-positive and COVID-19-negative patients. We trained nine identical DL-based classification models by using combinations of the datasets with a 72% train, 8% validation, and 20% test data split. The models trained on a single dataset achieved accuracy/area under the receiver operating characteristics curve (AUC) values of 0.87/0.826 (UTSW), 0.97/0.988 (CC-CCCI), and 0.86/0.873 (COVID-CTset) when evaluated on their own dataset. The models trained on multiple datasets and evaluated on a test set from one of the datasets used for training performed better. However, the performance dropped close to an AUC of 0.5 (random guess) for all models when evaluated on a different dataset outside of its training datasets. Including the MosMedData, which only contained positive labels, into the training did not necessarily help the performance on the other datasets. Multiple factors likely contribute to these results, such as patient demographics and differences in image acquisition or reconstruction, causing a data shift among different study cohorts.
Automatic segmentation of medical images with DL algorithms has proven to be highly successful. With most of these algorithms, inter-observer variation is an acknowledged problem, leading to sub-optimal results. This problem is even more significant in post-operative clinical target volume (post-op CTV) segmentation due to the absence of macroscopic visual tumor in the image. This study, using post-op CTV segmentation as the test bed, tries to determine if physician styles are consistent and learnable, if there is an impact of physician styles on treatment outcome and toxicity; and how to explicitly deal with physician styles in DL algorithms to facilitate its clinical acceptance. A classifier is trained to identify which physician has contoured the CTV from just the contour and corresponding CT scan, to determine if physician styles are consistent and learnable. Next, we evaluate if adapting automatic segmentation to physician styles would be clinically feasible based on a lack of difference between outcomes. For modeling different physician styles of CTV segmentation, a concept called physician style-aware (PSA) segmentation is proposed which is an encoder-multidecoder network trained with perceptual loss. With the proposed physician style-aware network (PSA-Net), Dice similarity coefficient (DSC) accuracy increases on an average of 3.4% for all physicians from a general model that is not style adapted. We show that stylistic contouring variations also exist between institutions that follow the same segmentation guidelines and show the effectiveness of the proposed method in adapting to new institutional styles. We observed an accuracy improvement of 5% in terms of DSC when adapting to the style of a separate institution.
In tumor segmentation, inter-observer variation is acknowledged to be a significant problem. This is even more significant in clinical target volume (CTV) segmentation, specifically, in post-operative settings, where a gross tumor does not exist. In this scenario, CTV is not an anatomically established structure but rather one determined by the physician based on the clinical guideline used, the preferred trade off between tumor control and toxicity, their experience, training background etc... This results in high inter-observer variability between physicians. Inter-observer variability has been considered an issue, however its dosimetric consequence is still unclear, due to the absence of multiple physician CTV contours for each patient and the significant amount of time required for dose planning. In this study, we analyze the impact that these physician stylistic variations have on organs-at-risk (OAR) dose by simulating the clinical workflow using deep learning. For a given patient previously treated by one physician, we use DL-based tools to simulate how other physicians would contour the CTV and how the corresponding dose distributions should look like for this patient. To simulate multiple physician styles, we use a previously developed in-house CTV segmentation model that can produce physician style-aware segmentations. The corresponding dose distribution is predicted using another in-house deep learning tool, which, averaging across all structures, is capable of predicting dose within 3% of the prescription dose on the test data. For every test patient, four different physician-style CTVs are considered and four different dose distributions are analyzed. OAR dose metrics are compared, showing that even though physician style variations results in organs getting different doses, all the important dose metrics except Maximum Dose point are within the clinically acceptable limit.
Low Dose Computed Tomography (LDCT) is clinically desirable due to the reduced radiation to patients. However, the quality of LDCT images is often sub-optimal because of the inevitable strong quantum noise. Inspired by their unprecedent success in computer vision, deep learning (DL)-based techniques have been used for LDCT denoising. Despite the promising noise removal ability of DL models, people have observed that the resolution of the DL-denoised images is compromised, decreasing their clinical value. Aiming at relieving this problem, in this work, we developed a more effective denoiser by introducing a high-resolution network (HRNet). Since HRNet consists of multiple branches of subnetworks to extract multiscale features which are later fused together, the quality of the generated features can be substantially enhanced, leading to improved denoising performance. Experimental results demonstrated that the introduced HRNet-based denoiser outperforms the benchmarked UNet-based denoiser in terms of superior image resolution preservation ability while comparable, if not better, noise suppression ability. Quantitative metrics in terms of root-mean-squared-errors (RMSE)/structure similarity index (SSIM) showed that the HRNet-based denoiser can improve the values from 113.80/0.550 (LDCT) to 55.24/0.745 (HRNet), in comparison to 59.87/0.712 for the UNet-based denoiser.
Monte Carlo (MC) simulation is considered the gold standard method for radiotherapy dose calculation. However, achieving high precision requires a large number of simulation histories, which is time consuming. The use of computer graphics processing units (GPUs) has greatly accelerated MC simulation and allows dose calculation within a few minutes for a typical radiotherapy treatment plan. However, some clinical applications demand real time efficiency for MC dose calculation. To tackle this problem, we have developed a real time, deep learning based dose denoiser that can be plugged into a current GPU based MC dose engine to enable real time MC dose calculation. We used two different acceleration strategies to achieve this goal: 1) we applied voxel unshuffle and voxel shuffle operators to decrease the input and output sizes without any information loss, and 2) we decoupled the 3D volumetric convolution into a 2D axial convolution and a 1D slice convolution. In addition, we used a weakly supervised learning framework to train the network, which greatly reduces the size of the required training dataset and thus enables fast fine tuning based adaptation of the trained model to different radiation beams. Experimental results show that the proposed denoiser can run in as little as 39 ms, which is around 11.6 times faster than the baseline model. As a result, the whole MC dose calculation pipeline can be finished within 0.15 seconds, including both GPU MC dose calculation and deep learning based denoising, achieving the real time efficiency needed for some radiotherapy applications, such as online adaptive radiotherapy.
Low dose computed tomography (LDCT) is desirable for both diagnostic imaging and image guided interventions. Denoisers are openly used to improve the quality of LDCT. Deep learning (DL)-based denoisers have shown state-of-the-art performance and are becoming one of the mainstream methods. However, there exists two challenges regarding the DL-based denoisers: 1) a trained model typically does not generate different image candidates with different noise-resolution tradeoffs which sometimes are needed for different clinical tasks; 2) the model generalizability might be an issue when the noise level in the testing images is different from that in the training dataset. To address these two challenges, in this work, we introduce a lightweight optimization process at the testing phase on top of any existing DL-based denoisers to generate multiple image candidates with different noise-resolution tradeoffs suitable for different clinical tasks in real-time. Consequently, our method allows the users to interact with the denoiser to efficiently review various image candidates and quickly pick up the desired one, and thereby was termed as deep interactive denoiser (DID). Experimental results demonstrated that DID can deliver multiple image candidates with different noise-resolution tradeoffs, and shows great generalizability regarding various network architectures, as well as training and testing datasets with various noise levels.